When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr ...

publicly available map to show the impact of mutations on where proteins ... The name cystic fibrosis refers to the characteristic scarring (fibrosis) and cyst formation within the pancreas ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...

Though most hiccups are harmless and fade away quickly, some can be painful or persistent. To figure out why, experts suggest paying attention to other symptoms that might accompany those odd ...

For about a decade after the premiere of the very first season of True Detective, it seemed like all anyone wanted to make was in that show's shadow: an "[insert-number of episodes here]-hour ...